Denka Seiken Co plans to double the existing vaccine bulk materials production facilities.
This content is only available to subscribers.
Forgot your password? Click here
Don't have any login details?
Free Trial Access
09
Nov
2018
Influenza vaccine manufacturing facility, JapanBy:Creamer Media Research Coordinator & Senior Deputy Editor Denka Seiken Co plans to double the existing vaccine bulk materials production facilities.
This content is only available to subscribers.
Forgot your password? Click here
Don't have any login details?
Free Trial Access
|